Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can cause heartburn. Acid reflux and indigestion are recognised side effects of tirzepatide, listed in the medicine's prescribing information and reported by a meaningful proportion of people starting treatment. They are most common in the first few weeks or after a dose increase, and for most people they ease as the body adjusts. These are prescription-only medicines; a GPhC-registered prescriber reviews whether they are clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you finish a meal that would have felt perfectly comfortable a month ago, and within twenty minutes there is a familiar burning sensation rising behind your breastbone. If you started Mounjaro recently, or just moved to a higher dose, tirzepatide is probably part of the explanation.
Mounjaro works partly by slowing gastric emptying, the rate at which food moves from your stomach into the small intestine. That mechanism is central to why it reduces appetite so effectively, but it also means the stomach holds onto food for longer than usual. A fuller stomach for a longer period puts more pressure on the lower oesophageal sphincter, the valve that should stop stomach acid travelling upward. When that valve is under pressure, acid reflux and the heartburn sensation that comes with it follow. The NHS tirzepatide medicines page lists indigestion, acid reflux and burping among the recognised side effects of the medicine.
This is not a sign that something has gone wrong. It is a predictable consequence of how tirzepatide acts on the digestive system, and it is worth knowing that the effect is usually most pronounced during the first four to eight weeks or in the week or two after your dose steps up. Your stomach is adjusting to a slower rhythm, and for most people that adjustment does eventually happen.
If heartburn was something you dealt with before starting treatment, you may find it temporarily more noticeable. If it is entirely new to you, the association with Mounjaro is almost certainly the reason, and you may find it reassuring to read about whether Mounjaro gives you headaches, since some people notice several new symptoms arriving around the same time and wonder how they connect.
The timing matters. Gastrointestinal side effects from GLP-1 and dual GIP/GLP-1 medicines like Mounjaro tend to cluster around two windows: the first few weeks of treatment at any dose, and the days immediately following a dose increase. The SURMOUNT-1 trial, published in the New England Journal of Medicine, documented GI side effects as the most common adverse events, with the majority graded mild to moderate and most resolving without stopping treatment.
For heartburn specifically, people often describe it as worst in the evenings, particularly if dinner was larger than planned or eaten late. Lying down shortly after a meal compounds the problem because gravity no longer helps keep stomach contents where they belong. Keeping a Mounjaro pen in the fridge door is a useful routine anchor, it is also a reminder that your injection day is coming and that you may want to eat lighter around that window.
Relief tends to arrive gradually rather than suddenly. By week six to eight at a stable dose, many people find symptoms have softened considerably. If you are still finding heartburn disruptive at week ten with no improvement, that is a conversation for your prescriber rather than something to manage indefinitely on your own. You can read more about managing Mounjaro side effects across the titration journey.
One question worth asking is whether any other medicines or supplements you take contribute. Some common items (aspirin, anti-inflammatory pain relief, certain vitamins taken without food) can irritate the oesophagus independently. Your prescriber can help unpick what is Mounjaro and what is not.
There is no single fix, but a combination of small adjustments tends to make a real difference. Eating smaller portions more frequently is probably the most effective single change, because it limits how much food the stomach holds at any one time. With gastric emptying already slowed, a large meal leaves very little room for the valve to stay comfortable.
Eating slowly matters too. Taking twenty to thirty minutes over a meal rather than ten gives the stomach more time to signal fullness before you have eaten past the point of comfort. Many people on Mounjaro find their appetite has already shifted, use that signal, not the size of the plate.
Staying upright for at least forty-five minutes after eating is straightforward in principle but easy to skip after an evening meal. A short walk works well; sitting in a chair is fine; lying on the sofa is not ideal. If symptoms are worse at night, raising the head of the bed slightly (or simply using an extra pillow) reduces night-time reflux for many people.
Common dietary triggers are worth reviewing: fatty or heavily spiced food, caffeine, fizzy drinks and citrus tend to aggravate reflux regardless of Mounjaro, but they may feel more provocative now. Alcohol relaxes the lower oesophageal sphincter directly and combines poorly with an already-full stomach.
Over-the-counter antacids are generally safe alongside tirzepatide, but always check with a pharmacist or your prescriber before adding anything new, particularly if you take other regular medicines. For a fuller picture of heartburn management specific to Mounjaro, including when prescription reflux medicines might be appropriate, the linked page goes into more detail. The broader Mounjaro side effects overview covers everything from nausea to eggy burps and diarrhoea, which sometimes accompany acid reflux during the early weeks.
Ordinary heartburn is uncomfortable but not dangerous. However, severe or persistent upper-abdominal pain (especially pain that spreads to the back, or that comes with vomiting you cannot control) should not be attributed to ordinary reflux and brushed aside. The MHRA has highlighted acute pancreatitis as a known but infrequent serious side effect of GLP-1 medicines; the symptom profile overlaps with severe reflux, which is exactly why distinguishing the two matters.
Contact your prescriber or seek urgent medical attention if: the pain is severe and does not ease within a short time; you develop a fever alongside the abdominal pain; vomiting is persistent and you cannot keep fluids down; or you notice new symptoms such as yellowing of the skin or eyes. These go beyond what tirzepatide-related heartburn normally produces.
You can also report side effects you experience through the MHRA's Yellow Card scheme, it is open to patients as well as clinicians, and reports from people taking the medicine contribute to ongoing safety monitoring.
If heartburn is making you consider stopping treatment before giving the dose time to settle, speak to your prescriber first. There are often workable adjustments (dose-timing changes, dietary tweaks, short-term reflux relief) that make continuing feasible. Our clinical team reviews every patient's experience as part of ongoing care, not just at the point of starting. If you have not yet started treatment and want to understand whether Mounjaro is clinically appropriate for you, you can check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.